Holen Sie sich die Stockscreener-App
1.92
1.28%
-0.04
Schlusskurs vom Vortag:
$1.96
Offen:
$1.94
24-Stunden-Volumen:
122.32K
Relative Volume:
0.53
Marktkapitalisierung:
$117.77M
Einnahmen:
$14.18M
Nettoeinkommen (Verlust:
$-82.66M
KGV:
-1.4769
EPS:
-1.3
Netto-Cashflow:
$-50.80M
1W Leistung:
-7.42%
1M Leistung:
+11.21%
6M Leistung:
-2.27%
1J Leistung:
-0.77%
1-Tages-Spanne:
$1.92
$1.975
1-Wochen-Bereich:
$1.93
$2.14
52-Wochen-Spanne:
$1.56
$2.625
Seer Inc Stock (SEER) Company Profile
Firmenname
Seer Inc
Sektor
Branche
Telefon
650-453-0000
Adresse
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Vergleichen Sie SEER mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.92 | 117.77M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
503.87 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.19 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
628.54 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
257.39 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
248.45 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-08-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2020-12-29 | Eingeleitet | BofA Securities | Neutral |
| 2020-12-29 | Eingeleitet | Cowen | Outperform |
| 2020-12-29 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-29 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Seer Inc Aktie (SEER) Neueste Nachrichten
Seer (NASDAQ:SEER) Shares Down 2.5% – What’s Next? - Defense World
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 | SEER Stock News - GuruFocus
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewswire
Seer, Inc. to Report Q1 2025 Financial Results on May 13, 2025 - Nasdaq
Seer Earnings Preview: Proteomics Pioneer Readies Q1 2025 Financial Results for May 13 Release - Stock Titan
Veracyte data joins NCI SEER database for research - Investing.com
Cadwell invests in Australian company Seer Medical - Yahoo
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics - Yahoo Finance
Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st
Seer : Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference - MarketScreener
Corient Private Wealth LLC Acquires 13,200 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED - GlobeNewswire
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED BIOCHAR, MONETIZE AND TOKENIZE ASSETS AND CARBON CREDITS AND DEVELOP TURBINE BLADE TREATMENT TECHNOLOGY - Yahoo
After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - MSN
After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - Yahoo Finance
The SEER Group Expands in Oregon with Acquisition of Alpine Heating & Air Conditioning - Yahoo Finance
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates - MSN
Large Tools and Labs Optimistic at TD Cowen Health Conference By Investing.com - Investing.com Australia
Large Tools and Labs Optimistic at TD Cowen Health Conference - Investing.com India
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look Fo - GuruFocus.com
SEER, INC. : Results of Operations and Financial Condition (form 8-K) -January 25, 2021 at 04:40 pm EST - marketscreener.com
Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround - Yahoo Finance
Y Intercept Hong Kong Ltd Acquires New Shares in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. Earnings Call: Mixed Sentiment and Optimistic Outlook - TipRanks
Seer, Inc. SEC 10-K Report - TradingView
Seer Full Year 2024 Earnings: In Line With Expectations - Yahoo Finance
Teams at Neptune Beach's Fletcher High win spots at national investment competition - MSN
Seer, Inc. (NASDAQ:SEER) Q4 2024 Earnings Call Transcript - Insider Monkey
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Rev - GuruFocus.com
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... - Yahoo Finance
Seer, Inc. Reports 2024 Earnings and 2025 Outlook - TipRanks
Seer Inc (SEER) Q4 2024 Earnings: Revenue Beats at $4.0M, EPS Mi - GuruFocus.com
Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Seer Inc. reports Q4 2024 revenue decline, stock rises - Investing.com
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook - The Manila Times
Can Seer's New Proteomics Application Drive Its Ambitious 24% Revenue Growth Target? - StockTitan
Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025 - Technology Networks
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Seer Inc. (SEER) Earnings Preview: Q4 2024 Revenue Expected to Decline 11% - HPBL
Monash University's Proteomics & Metabolomics Platform Strengthens Partnerships with Seer and Thermo Fisher Scientific - Monash University
Seer to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Seer's Proteomics Platform Disrupt Healthcare? Management Reveals Strategy Next Week - StockTitan
Seer (SEER) Expected to Announce Quarterly Earnings on Thursday - Defense World
Seer to Feature Proteomic Advancements in Cancer and RNA - GlobeNewswire
US Penny Stocks: 3 Picks With Market Caps As Low As $70M - Simply Wall St
Seer, Inc. to Showcase Innovations in Proteomics at US HUPO 2025 Annual Conference - Nasdaq
Finanzdaten der Seer Inc-Aktie (SEER)
Umsatz
Nettogewinn
Free Cashflow
ENV
Seer Inc-Aktie (SEER) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Feb 04 '25 |
Sale |
2.24 |
8,068 |
18,044 |
1,428,217 |
| Nishar Dipchand | Director |
Jun 14 '24 |
Sale |
1.78 |
12,109 |
21,512 |
79,457 |
1.36%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):